Organization · Venture Capital
CRB Health Tech SGEIC
CRB Health Tech SGEIC is a venture capital management firm based in Spain, specializing in health technologies including biotech, medical devices, and digital health. The firm invests in various stages, primarily focusing on enhancing healthcare access and efficiency.
Overview
What CRB Health Tech SGEIC does
What CRB Health Tech SGEIC is
CRB Health Tech SGEIC is a venture capital management firm based in Spain, specializing in health technologies including biotech, medical devices, and digital health. The firm invests in various stages, primarily focusing on enhancing healthcare access and efficiency.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2008
- Approximate age
- About 18 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find CRB Health Tech SGEIC elsewhere
Open the official website or a supported primary organization account.
Capability profile
CRB Health Tech SGEIC as a funder
Investment thesis
CRB Health Tech invests in health technologies that enhance healthcare access, efficiency, and patient empowerment, focusing on the convergence of digital technologies and healthcare.
Focus narrative
CRB Health Tech invests in health technologies at various stages, including seed and Series A. Their investment strategy emphasizes the convergence of digital technologies and healthcare, targeting opportunities that enhance healthcare access, efficiency, and patient empowerment. The firm primarily operates in Spain and across Europe, with ticket sizes ranging from €500,000 to €1.5 million, and up to €4-5 million per company.
Value beyond capital
CRB Health Tech adds value to its portfolio companies by leveraging its expertise in health technologies, providing strategic guidance, and facilitating connections within the healthcare ecosystem to enhance growth and market reach.
Terms and economics
- Typical check
- $500,000–$1,500,000
- Sweet spot
- $2,000,000
Focus and fit
- Stages
- Seed · Series A
- Sectors
- Healthcare · Biotech · Digital Health · Medical Devices
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
CRB Health Tech's portfolio includes notable companies such as: Health in Code: Market stage diagnostic drug for hypolactasia. TCD Pharma: First-in-class small molecule for the targeted treatment of solid tumors. Green Molecular: Pterostilbene formulations for dermatology and oncology. OWL Metabolomics: Metabolomic platform with the first marketed non-invasive diagnostic LDT for NASH. Thryve: SaaS platform for 24/7 health data access from consumer wearables. Carol: Virtual primary care for employees.
Common questions
What to know about CRB Health Tech SGEIC
Upseed classifies CRB Health Tech SGEIC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.